Therefore, IGHV4-34 is associated with the onset of autoimmune diseases, and a previous analysis of the BCR repertoire in patients with systemic lupus erythematosus has reported increased IGHV4-34 during the acute phases [47]. Here, BCR is linked to autoimmune disease.